🤖 OpenAI Debuts “ChatGPT Agent,” a Self-Operating Assistant
OpenAI CEO Sam Altman announced today the launch of “ChatGPT Agent,” describing it as a step beyond traditional copilots. The Agent can autonomously perform multi-step operations—like researching, organizing information, and executing tasks on its own computer. It marries the deep reasoning of research-focused AI with the hands-on utility of tools like Operate, promising a leap in AI’s ability to manage real-world workflows.
🏗️ Meta to Build AI Data Center Size of Manhattan
Meta will invest hundreds of billions in AI, including building data centers as large as Manhattan. CEO Mark Zuckerberg announced projects like Prometheus and Hyperion to power next-gen AI tools. Fueled by strong ad revenue, Meta sees AI as its future. Its new Superintelligence Labs, led by top hires, will drive the push forward against rivals like OpenAI.
🦾 Slack’s AI Will Decode Office Jargon for You
Slack is rolling out AI tools that explain confusing company jargon and automate writing tasks to boost productivity. A new feature will break down acronyms and team lingo using past workspace conversations. Another AI assistant will summarize chats, extract action items, and rewrite notes in different tones. These updates aim to streamline work, not swamp it.
🧐 Mistral’s Le Chat Adds Deep Research Mode
Mistral’s Le Chat now features a deep research mode, multilingual reasoning, and image editing—pushing it closer to rivals like OpenAI. The upgrade enables users to search and synthesize info across the web and their own enterprise data, all without cloud uploads. With project organization tools and local data connectors, Le Chat is now built for real work.
Enjoying our newsletter? Forward it to a colleague—
it’s one of the best ways to support us.
🤔 FRIDAY FACTS
How Accurately Can AI Predict Heart Failure?
Doctors are now using AI to help identify patients at risk of heart failure, early enough to make a real difference.
Stick around to find out! 👇
🗺️ GEOPOLITICS
NVIDIA’s Jensen Huang Wins Back AI Chip Sales to China
Jensen Huang, CEO of NVIDIA, persuaded the Trump administration to reverse its ban on AI chip sales to China, a pivotal shift in U.S. tech policy. After months of lobbying—including travel with Trump, congressional testimony, and meetings with key insiders like White House AI adviser David Sacks—Huang successfully argued that blocking sales would cede ground to Chinese firms like Huawei.
His pitch: Let the world build on U.S. chips, not alternatives. Trump eventually agreed to allow sales of NVIDIA’s H20 chip, less powerful than top-tier models. The decision highlights Huang’s rise as a geopolitical force and cements NVIDIA’s role as the $4 trillion backbone of global AI infrastructure. → Read the full article here.
🧪 BIOTECH
AI Drug Discovery Faces Its Proving Ground: Can Machine-Led Molecules Win?
Biotech startups like Recursion, Insilico, and Xaira are wagering that AI can rewrite the rules of drug development, where more than 90% of candidates fail before reaching market. These firms use AI to design and vet molecules faster and more efficiently, sometimes creating viable candidates after testing just a few hundred compounds instead of thousands.
A handful of AI-derived drugs, including Recursion’s REC-994 and Insilico’s ISM001-055, have reached Phase II trials, but none have been approved yet. As billions pour into the space, the central question remains: Can AI make drug discovery faster, cheaper, and more effective—or is it just another high-tech gamble in a field already full of risk? → Read the full article here.
🛰️ NEWS
What Else is Happening
🥇 AI Talent Wars = NBA Free Agency: Perplexity’s CEO says recruiting top researchers now mirrors NBA free agency, star talent has major leverage as Big Tech dangles huge paychecks and personal pitches.
✨ Lovable Becomes Sweden’s Newest Unicorn: Stockholm’s ‘vibe coding’ startup raised $200M at a $1.8B valuation, leading Europe’s push into AI-assisted app building for non-coders.
💰 $1B Pledged for AI Frontline Tools: Gates Foundation, Ballmer Group and others launch NextLadder to fund AI that helps social workers, public defenders, and parole officers—not replace them.
🚧 UAE-NVIDIA AI Chip Deal Stalls: A multibillion-dollar deal for UAE to buy NVIDIA AI chips is paused over U.S. fears the tech could be smuggled to China, despite Gulf nations' promises of safeguards.
🛡️ Confident Security Debuts with $4.2M: The startup promises “Signal for AI” privacy with end-to-end encrypted tools that keep prompts hidden—even from model providers, unlocking sensitive enterprise use.
🏷️ OpenAI Eyes Cut of ChatGPT Sales: The company plans to add in-app checkout and charge commissions on eCommerce sales, turning free users into revenue and rivaling Google’s search-based shopping model.
📽️ VIDEO
Perplexity CEO: Browser Wars, Taking on Google, White Collar Jobs and More!
Matt sits down with Perplexity CEO Aravind Srinivas to discuss browser wars, labor displacement, taking on Google, and more. Get the full scoop! 👇
🧰 TOOLBOX
Smarter Studying, Faster Prototyping, and Streamlined HR
📚 Coursable: Boost study sessions with AI flashcards, quizzes, summaries & doc chat—perfect for personalized, efficient learning.
✏️ Sketch2App: Turn hand-drawn app sketches into clean, usable code—ideal for rapid prototyping and streamlining UI/UX workflows.
🎯 Dayforce: All-in-one HCM platform for payroll, benefits, talent & analytics—streamlines HR operations and boosts workforce productivity.
👉️ Find trending AI tools: Browse the Forward Future AI Tool Library
🗒️ FEEDBACK
Help Us Get Better
What did you think of today's newsletter? |
🤔 FRIDAY FACTS
AI Can Predict Heart Failure Risk with 83% Accuracy
Mayo Clinic has developed an AI model that predicts the risk of death from heart failure within one year, and it does so with 83% accuracy. The system doesn’t rely solely on numbers from lab results; instead, it uses natural language processing (NLP) to analyze unstructured clinical notes, scanning for subtle clues that may signal declining heart health.
This approach allows the AI to flag high-risk patients earlier, helping care teams intervene sooner and prioritize limited resources more effectively. It’s already being tested in clinical settings to support real-time triage.
In short, AI’s not replacing doctors anytime soon, but it’s proving to be a sharp-eyed assistant when it comes to spotting silent signs of danger.
That’s a Wrap!
❤️ Love Forward Future? Spread the word & earn rewards! Share your unique referral link with friends and colleagues to unlock exclusive Forward Future perks! 👉 Get your link here.
📢 Want to advertise with Forward Future? Reach 500K+ AI enthusiasts, tech leaders, and decision-makers. Let’s talk—just reply to this email.
🛰️ Want more Forward Future? Follow us on X for quick updates, subscribe to our YouTube for deep dives, or add us to your RSS Feed for seamless reading.
Thanks for reading today’s newsletter—see you next time!
Matthew Berman & The Forward Future Team
🧑🚀 🧑🚀 🧑🚀 🧑🚀
